By Don Nico Forbes
Steris said the trial against its Isomedix subsidiary was dismissed and will be rescheduled for a later date.
The Irish medical-device company said the case, which began on Dec. 4, was declared a mistrial on Friday at the plaintiff's request after the dismissal of a juror reduced the jury to fewer than twelve.
The trial was set to address a claim that ethylene-oxide emissions from a sterilization facility in Waukegan, Illinois--which Isomedix owned and operated from 2005 to 2008--caused personal injury.
The Illinois court will schedule the case for retrial at a later date, the company said.
On Nov. 7, Steris disclosed that it was facing hundreds of lawsuits alleging harm arising from its use of ethylene oxide in the sterilization of medical devices.
"Isomedix intends to continue to vigorously defend against [the] allegations," it said.
Write to Don Nico Forbes at don.forbes@wsj.com
(END) Dow Jones Newswires
January 21, 2025 07:04 ET (12:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.